Abstract:Background: Targeting the CD47/SIRPα signaling pathway represents a novel approach to enhance anti-tumor immunity. However, the crystal structure of the CD47/SIRPα has not been fully studied. This study aims to analyze the structure interface of the complex of CD47 and IMM01, a novel recombinant SIRPα-Fc fusion protein. Methods: IMM01-Fab/CD47 complex was crystalized, and diffraction images were collected. The complex structure was determined by molecular replacement using the program PHASER with the CD47-SIRPαv2 structure (PDB code 2JJT) as a search model. The model was manually built using the COOT program and refined using TLS parameters in REFMAC from the CCP4 program suite. Results: Crystallization and structure determination analysis of the interface of IMM01/CD47 structure demonstrated CD47 surface buried by IMM01. Comparison with the literature structure (PDB ID 2JJT) showed that the interactions of IMM01/CD47 structure are the same. All the hydrogen bonds that appear in the literature structure are also present in the IMM01/CD47 structure. These common hydrogen bonds are stable under different crystal packing styles, suggesting that these hydrogen bonds are important for protein binding. In the structure of human CD47 in complex with human SIRPα, except SER66, the amino acids that form hydrogen bonds are all conserved. Furthermore, comparing with the structure of PDB ID 2JJT, the salt bridge interaction from IMM01/CD47 structure are very similar, except the salt bridge bond between LYS53 in IMM01 and GLU106 in CD47, which only occurs between the B and D chains. However, as the side chain conformation of LYS53 in chain A is slightly different, the salt bridge bond is absent between the A and C chains. At this site between chain A and chain C, there are a salt bridge bond between LYS53 (A) and GLU104 (C) and a salt bridge bond between HIS56 (A) and GLU106 (C) instead. According to the sequence alignment results of SIRPα, SIRPβ and SIRPγ in the literature of PDB ID 2JJT, except ASP100, the amino acids that form common salt bridge bonds are all conserved. Conclusion: Our data demonstrated crystal structure of the IMM01/CD47 complex and provides a structural basis for the structural binding interface and future clinical applications.

Crystal Structure of HAb18G/CD147: IMPLICATIONS FOR IMMUNOGLOBULIN SUPERFAMILY HOMOPHILIC ADHESION

Dimerization is essential for HAb18G/CD147 promoting tumor invasion via MAPK pathway.

HAb18G/CD147-mediated Calcium Mobilization and Hepatoma Metastasis Require Both C-terminal and N-terminal Domains

Involvement of HAb18G/CD147 in T cell activation and immunological synapse formation.

Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A)

The glycosylation characteristic of hepatoma-associated antigen HAb18G/CD147 in human hepatoma cells.

Extracellular Membrane-proximal Domain of HAb18G/CD147 Binds to Metal Ion-dependent Adhesion Site (MIDAS) Motif of Integrin β1 to Modulate Malignant Properties of Hepatoma Cells

HAb18G/CD147 Regulates Vinculin-Mediated Focal Adhesion and Cytoskeleton Organization in Cultured Human Hepatocellular Carcinoma Cells.

Conformational Transitions and Activation of the Adhesion Receptor CD97.

HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma

Crystal structure of human CD38 extracellular domain.

The Interaction of HAb18G/CD147 with Integrin Α6β1 and Its Implications for the Invasion Potential of Human Hepatoma Cells

Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma.

Structural Insights into Immunoglobulin M

HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection

Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking

HAb18G/CD147 is Involved in TGF‐β‐induced Epithelial‐mesenchymal Transition and Hepatocellular Carcinoma Invasion

Hab18g/Cd147 Promotes Activation of Hepatic Stellate Cells and is A Target for Antibody Therapy of Liver Fibrosis

Crystal Structure Of The Human Cd4 N-Terminal Two-Domain Fragment Complexed To A Class Ii Mhc Molecule

Human IgG 1 C γ 1 Domain Is Crucial for the Bioactivity of the Engineered Anti-CD 20 Antibodies

Regulation of matrix metalloproteinase production and tumor cell invasion by four monoclonal antibodies against different epitopes of HAb18G/CD147 extracellular domain